Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients

BACKGROUND: Rejection remains the leading cause of allograft loss, and a major barrier to improving long-term outcomes after intestinal transplantation. Our aim is to define the prevalence and investigate the role of donor-specific antibody (DSA) on intestinal graft outcomes. METHODS: The study incl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transplantation
Autors principals: Cheng, Elaine Y., Everly, Matthew J., Kaneku, Hugo, Banuelos, Nubia, Wozniak, Laura J., Venick, Robert S., Marcus, Elizabeth A., McDiarmid, Suzanne V., Busuttil, Ronald W., Terasaki, Paul I., Farmer, Douglas G.
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer 2017
Matèries:
Original Clinical Science—General
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228620/
https://ncbi.nlm.nih.gov/pubmed/27490417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000001391
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars